These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 155294)

  • 21. [Effects of ipratropium bromide (IPB) and its combination with salbutamol sulfate (SAS) in acute asthmatic attack].
    Chen L; Deng K; Ye YQ
    Zhonghua Nei Ke Za Zhi; 1989 Nov; 28(11):657-60, 700. PubMed ID: 2534373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
    Barnes D; Delaney JC
    Br J Clin Pract; 1988 Sep; 42(9):372-6. PubMed ID: 2978246
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of the bronchodilating effects of ipratropium bromidefenoterol in comparison with carbuterol].
    Mistretta A; Crimi N; Palermo F; Gibellino F; Distefano SM; Vancheri C
    Arch Monaldi; 1983; 38(5-6):273-8. PubMed ID: 6238582
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol.
    Burge PS; Harries MG; l'Anson E
    Br J Dis Chest; 1980 Jul; 74(3):259-62. PubMed ID: 6448620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
    Pasotti C; Capra A; Vibelli C
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children.
    Iramain R; López-Herce J; Coronel J; Spitters C; Guggiari J; Bogado N
    J Asthma; 2011 Apr; 48(3):298-303. PubMed ID: 21332430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventilatory response to carbon dioxide in Nigerian asthmatics before and after aerosol salbutamol inhalation.
    Elegbeleye OO; Afonja AO; Femi-Pearse D
    S Afr J Med Sci; 1975; 40(1):21-5. PubMed ID: 1162509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
    Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
    Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
    Friberg S; Graff-Lonnevig V
    Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of Berodual on spirometric indicators in patients with reversible bronchial stenosis].
    Kościńska M; Biernacki W; Zieliński J
    Pneumonol Pol; 1985 May; 53(5):235-9. PubMed ID: 2931673
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ultrasonic spray protection against bronchospasm. Comparison of fenoterol and a combination of salbutamol and ipratropium bromide].
    Gribaldo E; Ardizzi A; Oliaro A; Galietti F; Giorgis GE; Miravalle C
    Minerva Med; 1987 Oct; 78(20):1539-41. PubMed ID: 2959883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
    Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
    Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of an adrenergic-parasympatholytic aerosol combination on the respiratory function].
    Rossi A; Rampulla C; Nascimbene T; Casali L
    Minerva Med; 1979 Jan; 70(4):333-46. PubMed ID: 155228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma].
    Baños Hidalgo P; Ramos Martos A; Cabrera Moreno R; Luque Leal J; Palacios Giner A
    Rev Clin Esp; 1983 Nov; 171(4):265-8. PubMed ID: 6229844
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age on response to ipratropium and salbutamol in asthma.
    Ullah MI; Newman GB; Saunders KB
    Thorax; 1981 Jul; 36(7):523-9. PubMed ID: 6458920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilator responses to nebulised ipratropium and salbutamol singly and in combination in chronic bronchitis.
    Chan CS; Brown IG; Kelly CA; Dent AG; Zimmerman PV
    Br J Clin Pharmacol; 1984 Jan; 17(1):103-5. PubMed ID: 6229262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ventilatory and associated effects of a synthetic anticholinergic, SCH 1,000, in obstructive bronchopathies].
    Pelucco D; Cerri E; Di Muzio M; Rossi GA
    Bronchopneumologie; 1976; 26(5):399-409. PubMed ID: 137769
    [No Abstract]   [Full Text] [Related]  

  • 40. Salbutamol and ipratropium in acute asthma.
    Rayner RJ; Cartlidge PH; Upton CJ
    Arch Dis Child; 1987 Aug; 62(8):840-1. PubMed ID: 2959208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.